EDAP Shares Are Still A Steal, But The Pandemic Could Be A Wrench

  • EDAP has developed an innovative HIFU treatment device for prostate and other cancers, which it was already selling.
  • The offering is boosted by an exclusive distribution deal with the maker of a complementary device and the upcoming Category 1 CPT reimbursement code.
  • The shares are a steal unless the COVID-19 pandemic worsens, as the company’s sales and finances are greatly affected by the pandemic.

Source: EDAP Shares Are Still A Steal, But The Pandemic Could Be A Wrench (NASDAQ:EDAP) | Seeking Alpha